Status:
TERMINATED
Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study
Lead Sponsor:
Karl-Andre Wian
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to reveal if higher doses of vasopressors in septic shock patients correlates with cerebral vasoconstriction and lower cerebral oximetry.
Detailed Description
The mortality with septic shock is high. Treatment includes antibiotics, intravenous fluid and drugs for circulatory support, especially the vasopressor norepinephrine. Fluids and drugs for circulator...
Eligibility Criteria
Inclusion
- 18 years or older
- Septic shock patients in ICU department requiring vasopressor therapy
Exclusion
- Damage to the frontal lobes corresponding to the area where SCO2 is monitored
- Patients in pharmacological studies
- Patients with known intracranial vascular anomalies or cerebral aneurysms
- Patients where vasoactive medication is started before cerebral oxymetry is established
- Patients with known neurological disease
- Patients with undergone cerebral insult, transient ischemic attack or carotid stenosis
- Patients who have been resuscitated after cardiac arrest in connection with this hospital stay
- Patients with a body temperature below 35 degrees Celsius when establishing monitoring
Key Trial Info
Start Date :
February 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02237833
Start Date
February 1 2015
End Date
January 1 2017
Last Update
April 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sykehuset i Vestfold HF
Tønsberg, Vestfold, Norway, N-3117